Please login to the form below

Not currently logged in
Email:
Password:

entecavir

This page shows the latest entecavir news and features for those working in and with pharma, biotech and healthcare.

J&J buys firm seeking hepatitis B cure

J&J buys firm seeking hepatitis B cure

There are several approved drugs to treat chronic infection with HIV - including pegylated interferons, generic antivirals such as lamivudine, adefovir dipivoxil, tenofovir, entecavir and Novartis still-in-patent Tyzeka/Sebivo (telbivudine).

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics